These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 28372798)

  • 1. Stimulation of HIV-specific T cell clonotypes using allogeneic HLA.
    Almeida CA; van Miert P; O'Driscoll K; Zoet YM; Chopra A; Watson M; de Santis D; Witt C; John M; Claas FHJ; D'Orsogna LJ
    Cell Immunol; 2017 Jun; 316():32-40. PubMed ID: 28372798
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug-induced alloreactivity: A new paradigm for allorecognition.
    D'Orsogna LJ; Almeida CM; van Miert P; Zoet YM; Anholts JDH; Chopra A; Watson M; Witt C; John M; Claas FHJ
    Am J Transplant; 2019 Sep; 19(9):2606-2613. PubMed ID: 31125485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The link between CD8⁺ T-cell antigen-sensitivity and HIV-suppressive capacity depends on HLA restriction, target epitope and viral isolate.
    Lissina A; Fastenackels S; Inglesias MC; Ladell K; McLaren JE; Briceño O; Gostick E; Papagno L; Autran B; Sauce D; Price DA; Saez-Cirion A; Appay V
    AIDS; 2014 Feb; 28(4):477-86. PubMed ID: 24384691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The avidity of cross-reactive virus-specific T cells for their viral and allogeneic epitopes is variable and depends on epitope expression.
    van den Heuvel H; Heutinck KM; van der Meer-Prins EMW; Franke-van Dijk MEI; van Miert PPMC; Zhang X; Ten Berge IJM; Claas FHJ
    Hum Immunol; 2018 Jan; 79(1):39-50. PubMed ID: 29100943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TCR clonotypes modulate the protective effect of HLA class I molecules in HIV-1 infection.
    Chen H; Ndhlovu ZM; Liu D; Porter LC; Fang JW; Darko S; Brockman MA; Miura T; Brumme ZL; Schneidewind A; Piechocka-Trocha A; Cesa KT; Sela J; Cung TD; Toth I; Pereyra F; Yu XG; Douek DC; Kaufmann DE; Allen TM; Walker BD
    Nat Immunol; 2012 Jun; 13(7):691-700. PubMed ID: 22683743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-functional-avidity cytotoxic T lymphocyte responses to HLA-B-restricted Gag-derived epitopes associated with relative HIV control.
    Berger CT; Frahm N; Price DA; Mothe B; Ghebremichael M; Hartman KL; Henry LM; Brenchley JM; Ruff LE; Venturi V; Pereyra F; Sidney J; Sette A; Douek DC; Walker BD; Kaufmann DE; Brander C
    J Virol; 2011 Sep; 85(18):9334-45. PubMed ID: 21752903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cross-reactive memory T cells for Epstein-Barr virus augment the alloresponse to common human leukocyte antigens: degenerate recognition of major histocompatibility complex-bound peptide by T cells and its role in alloreactivity.
    Burrows SR; Silins SL; Khanna R; Burrows JM; Rischmueller M; McCluskey J; Moss DJ
    Eur J Immunol; 1997 Jul; 27(7):1726-36. PubMed ID: 9247584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Despite biased TRBV gene usage against a dominant HLA B57-restricted epitope, TCR diversity can provide recognition of circulating epitope variants.
    Simons BC; Vancompernolle SE; Smith RM; Wei J; Barnett L; Lorey SL; Meyer-Olson D; Kalams SA
    J Immunol; 2008 Oct; 181(7):5137-46. PubMed ID: 18802118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frequency of class I HLA-restricted anti-HIV CD8+ T cells in individuals receiving highly active antiretroviral therapy (HAART).
    Gray CM; Lawrence J; Schapiro JM; Altman JD; Winters MA; Crompton M; Loi M; Kundu SK; Davis MM; Merigan TC
    J Immunol; 1999 Feb; 162(3):1780-8. PubMed ID: 9973442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New tools to monitor the impact of viral infection on the alloreactive T-cell repertoire.
    D'Orsogna LJ; Amir AL; Zoet YM; van der Meer-Prins PM; van der Slik AR; Kester MG; Heemskerk MH; Doxiadis II; Roelen DL; Claas FH
    Tissue Antigens; 2009 Oct; 74(4):290-7. PubMed ID: 19624615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA Vaccination by Electroporation Amplifies Broadly Cross-Restricted Public TCR Clonotypes Shared with HIV Controllers.
    Mukhopadhyay M; Galperin M; Patgaonkar M; Vasan S; Ho DD; Nouël A; Claireaux M; Benati D; Lambotte O; Huang Y; Chakrabarti LA
    J Immunol; 2017 Nov; 199(10):3437-3452. PubMed ID: 28993513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interdisciplinary analysis of HIV-specific CD8+ T cell responses against variant epitopes reveals restricted TCR promiscuity.
    Hoof I; Pérez CL; Buggert M; Gustafsson RK; Nielsen M; Lund O; Karlsson AC
    J Immunol; 2010 May; 184(9):5383-91. PubMed ID: 20363973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD8+ TCR Bias and Immunodominance in HIV-1 Infection.
    Kløverpris HN; McGregor R; McLaren JE; Ladell K; Harndahl M; Stryhn A; Carlson JM; Koofhethile C; Gerritsen B; Keşmir C; Chen F; Riddell L; Luzzi G; Leslie A; Walker BD; Ndung'u T; Buus S; Price DA; Goulder PJ
    J Immunol; 2015 Jun; 194(11):5329-45. PubMed ID: 25911754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA.
    Kiepiela P; Leslie AJ; Honeyborne I; Ramduth D; Thobakgale C; Chetty S; Rathnavalu P; Moore C; Pfafferott KJ; Hilton L; Zimbwa P; Moore S; Allen T; Brander C; Addo MM; Altfeld M; James I; Mallal S; Bunce M; Barber LD; Szinger J; Day C; Klenerman P; Mullins J; Korber B; Coovadia HM; Walker BD; Goulder PJ
    Nature; 2004 Dec; 432(7018):769-75. PubMed ID: 15592417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High responsiveness of HLA-B57-restricted Gag-specific CD8+ T cells in vitro may contribute to the protective effect of HLA-B57 in HIV-infection.
    Jansen CA; Kostense S; Vandenberghe K; Nanlohy NM; De Cuyper IM; Piriou E; Manting EH; Miedema F; van Baarle D
    Eur J Immunol; 2005 Jan; 35(1):150-8. PubMed ID: 15593302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T cell receptor cross-recognition of an HIV-1 CD8+ T cell epitope presented by closely related alleles from the HLA-A3 superfamily.
    Lichterfeld M; Williams KL; Mui SK; Shah SS; Mothe BR; Sette A; Kim A; Johnston MN; Burgett N; Frahm N; Cohen D; Brander C; Rosenberg ES; Walker BD; Altfeld M; Yu XG
    Int Immunol; 2006 Jul; 18(7):1179-88. PubMed ID: 16772368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subdominant Gag-specific anti-HIV efficacy in an HLA-B*57-positive elite controller.
    Leitman EM; Willberg CB; De Burgh-Thomas A; Streeck H; Goulder PJ; Matthews PC
    AIDS; 2016 Mar; 30(6):972-4. PubMed ID: 26959357
    [No Abstract]   [Full Text] [Related]  

  • 18. The HIV-1 antisense protein (ASP) induces CD8 T cell responses during chronic infection.
    Bet A; Maze EA; Bansal A; Sterrett S; Gross A; Graff-Dubois S; Samri A; Guihot A; Katlama C; Theodorou I; Mesnard JM; Moris A; Goepfert PA; Cardinaud S
    Retrovirology; 2015 Feb; 12():15. PubMed ID: 25809376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of allo-HLA cross-reactivity by virus-specific memory T-cell clones using single HLA-transfected K562 cells.
    D'Orsogna LJ; van der Meer-Prins EM; Zoet YM; Roelen DL; Doxiadis II; Claas FH
    Methods Mol Biol; 2012; 882():339-49. PubMed ID: 22665243
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CTL recognition of HIV-1-infected cells via cross-recognition of multiple overlapping peptides from a single 11-mer Pol sequence.
    Hashimoto M; Akahoshi T; Murakoshi H; Ishizuka N; Oka S; Takiguchi M
    Eur J Immunol; 2012 Oct; 42(10):2621-31. PubMed ID: 22740036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.